BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Medicines for Malaria Venture (MMV) 

20, rte de Pré-Bois

Geneva 15    1215  Switzerland
Phone: 41-0-22-799-4060 Fax: 41-0-22-799-4061


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Services

Segment
Research





 Company News
Anacor Pharmaceuticals, Inc. and Medicines for Malaria Venture (MMV) Extend Development Agreement for AN3661 for the Treatment of Malaria 9/1/2011 9:04:27 AM    More...
Anacor Pharmaceuticals, Inc. Announces Development Agreement with Medicines for Malaria Venture (MMV) for the Treatment of Malaria 3/18/2011 10:53:00 AM    More...
Jomaa Pharma and Medicines for Malaria Venture (MMV) to Co-Develop Novel Malaria Treatment Based on Fosmidomycin 2/15/2011 10:25:53 AM    More...
Alnylam Pharmaceuticals (ALNY) Release: Medicines for Malaria Venture (MMV) Becomes First Product Development Partnership to Contribute Patents to the Pool for Open Innovation against Neglected Tropical Diseases 8/16/2010 8:21:55 AM    More...
Medicines for Malaria Venture (MMV) and Anacor Pharmaceuticals, Inc. Announce Collaboration to Apply Boron Chemistry Technology to Identify New Medicines for the Treatment of Malaria 4/26/2010 10:56:38 AM    More...
SCYNEXIS, Inc. And Medicines for Malaria Venture (MMV) Sign HEOS(R) Agreement 5/13/2009 10:08:49 AM    More...
Pfizer Inc. (PFE) and Medicines for Malaria Venture (MMV) Advancing International Research Efforts in the Fight against Malaria 4/22/2009 11:49:50 AM    More...
BioFocus DPI And Medicines for Malaria Venture (MMV) Collaborate To Identify Anti-Malarial Compounds 4/16/2009 11:25:31 AM    More...
Malaria: New Treatment is Upcoming Developed by the Italian Pharmaceutical Company sigma-tau New Data Confirm the Absence of Side Effects and the Benefit of the Simpler Treatment Schedule 1/16/2009 10:29:16 AM    More...
Progress by Genzyme Corporation (GENZ), the Broad Institute and Medicines for Malaria Venture (MMV) Toward Developing Drug Candidates for Malaria Highlighted at Tropical Medicine Meeting 12/12/2008 8:56:38 AM    More...
12